Visit the MPX Bioceutical Corporation Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
TORONTO, Feb. 12, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce its inclusion in the newly created Horizons Emerging Marijuana Growers Index ETF (AQN:HMJR) (“HMJR ETF” or the “Index”).
As Horizon’s second marijuana focused fund, the Index is designed to provide exposure to the performance of a basket of primarily North American publicly-listed small capitalization companies involved in the cultivation, production and/or distribution of marijuana. Stocks held within the Index will generally have an initial market capitalization of at least $50 million and less than $500 million, at the time of rebalancing, and up to a maximum market capitalization of $750 million. No issuer will represent more than 8% of the Index on each rebalance.
The HMJR ETF is expected to launch on February 14, 2018 and will trade on the Aequitas NEO Exchange.
MPX’s addition to the HMJR ETF is a significant milestone and a reflection of our growth and success to date. We anticipate our inclusion will help broaden our shareholder base and increase investor awareness. We will continue to work diligently to grow our presence in the U.S. and Canadian cannabis sectors, generating revenue growth and creating shareholder value.
Scott Boyes, Chairman, President and Chief Executive Office of MPX
About MPX Bioceutical Corporation
MPX, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises in Arizona operating under the Health for Life (dispensaries) and the award-winning Melting Point Extracts (high-margin concentrates wholesale) brands. The successful Health for Life brand operates in the rapidly growing Phoenix Metropolitan Statistical Area.
The recently acquired GreenMart of Nevada NLV, LLC (“GreenMart”) is an award winning licensed cultivation, production and wholesale business, licensed for both the medical and “adult use” sectors in Las Vegas, Nevada, and is already selling wholesale into the Nevada medical cannabis market. GreenMart has also optioned suitable locations and intends to enter the higher-margin retail arena by applying for at least two dispensary licenses in the Las Vegas market which will operate under the “Health for Life” brand.
The Company owns assets in Massachusetts supporting cultivation, production and up to three dispensaries, and with the closing of this most recent transaction, MPX manages two full service dispensaries and one producer in Maryland.
MPX continues to expand its U.S. footprint, and has recently acquired management companies that provide operational and other services to three dispensaries and one production license in Maryland. The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a cannabis production and sales license. In addition, the Company will continue its efforts to develop its legacy nutraceuticals business.
For further information, please contact:
The most reliable, fact-based information on MPX Bioceutical Corp found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.